What Is NAD IV Treatment and How Does It Work?

NAD IV treatment is the intravenous infusion of nicotinamide adenine dinucleotide, a molecule your cells already use in hundreds of metabolic reactions, directly into the bloodstream. The idea is straightforward: NAD+ levels decline with age and illness, and delivering the molecule by IV bypasses the digestive system to raise those levels quickly. Clinics now offer these infusions for everything from fatigue and addiction recovery to anti-aging, but the science behind the claims is still catching up with the marketing.

What NAD+ Actually Does in Your Cells

NAD+ is a coenzyme involved in redox reactions, which makes it central to how your cells produce energy.¹ Every time your body converts food into usable fuel, NAD+ is part of the process, shuttling electrons around inside mitochondria. But energy production is only part of the picture. NAD+ also serves as a raw material for enzymes called sirtuins, which influence DNA repair, gene expression, and how cells respond to stress.² Another class of enzymes that depend on NAD+ helps maintain the integrity of your genome by patching up damaged DNA.³

Think of NAD+ less as a vitamin and more as a molecular currency that your cells spend on essential maintenance tasks. When there is plenty of it, these repair and energy systems run smoothly. When levels drop, cells start falling behind on upkeep. This is why the age-related decline in NAD+ has attracted so much research attention: it appears to be both a marker and a possible driver of the wear and tear that accumulates as we get older.⁴

Why NAD+ Levels Fall With Age

Researchers have documented that NAD+ concentrations in various tissues drop over the course of a lifetime. The decline seems to result from a combination of increased consumption and decreased production. As you age, certain enzymes that break down NAD+ become more active, essentially burning through the supply faster. At the same time, the biosynthetic pathways that manufacture new NAD+ slow down.⁴ Changes in tissue composition with aging may also contribute: the mix of cell types in an organ shifts over decades, and some of those shifts reduce the tissue’s overall capacity to maintain NAD+ pools.

This decline has become a focal point in aging research because of NAD+’s downstream effects. Lower NAD+ means less fuel for sirtuins and DNA-repair enzymes, which could allow cellular damage to accumulate faster. Animal studies have repeatedly shown that restoring NAD+ levels in aged mice improves mitochondrial function and various markers of health. The leap from mice to humans, though, remains one of the biggest open questions in the field.⁵

How the IV Infusion Works in Practice

During NAD IV treatment, a sterile solution of NAD+ is dripped into a vein, typically in the arm, over the course of one to several hours. The duration depends on the dose and how well you tolerate the infusion, because going too fast tends to cause unpleasant side effects. In a real-world comparison study, participants receiving NAD+ IV had an average infusion time of about 97 minutes per session, while those receiving a precursor molecule intravenously averaged around 37 minutes.⁶ Some wellness clinics offer sessions lasting four hours or more for higher doses.

The rationale for choosing IV delivery over a pill is that NAD+ is a large molecule that gets broken down in the gut before much of it reaches your bloodstream. Infusing it directly into the blood should, in theory, deliver a bigger dose to your cells. But what actually happens once NAD+ hits the bloodstream is more complex than you might expect.

What Happens to NAD+ Once It Enters the Blood

A small pilot study tracking the fate of IV NAD+ during a six-hour infusion found something surprising: for the first two hours, there was no detectable increase in plasma NAD+ or its metabolites at all. The molecule was being pulled out of circulation almost as fast as it was dripped in.⁷ The pattern of breakdown products that eventually showed up in urine suggested that enzymes on cell surfaces were rapidly cleaving the NAD+ molecule before it could enter cells intact.

This raises a genuine puzzle: if infused NAD+ gets chopped up in the blood, how could it be raising intracellular NAD+ levels? One possibility is that the fragments, particularly nicotinamide, get taken up by cells and used as building blocks to reassemble NAD+ inside. There is also evidence that certain channel proteins on cell membranes can transport NAD+ or related molecules.⁸ But the honest answer is that scientists do not yet have a clear, widely accepted picture of exactly how IV NAD+ translates into higher NAD+ inside your cells. The clinical effects people report could be mediated by NAD+ fragments rather than by the intact molecule.

A small randomized pilot trial comparing direct NAD+ IV to IV nicotinamide riboside (NR, a precursor molecule) and placebo found that NAD+ IV did not raise whole-blood NAD+ levels at 3 hours. NR IV, by contrast, boosted whole-blood NAD+ by about 21% at the 3-hour mark. Interestingly, the NAD+ IV group showed a slow, delayed rise, reaching roughly 15% above baseline by day 14.⁹ These are very small studies with limited participants, so the numbers should be treated as preliminary. But they do suggest the pharmacology is not as simple as “put NAD+ in, NAD+ goes up.”

Side Effects During and After Infusion

NAD+ IV infusions are not especially comfortable. The most commonly reported adverse effects include nausea, abdominal cramping, diarrhea, vomiting, increased heart rate, and chest pressure.⁶ In the real-world comparison study mentioned earlier, every single participant in the NAD+ IV group reported moderate to severe gastrointestinal symptoms and chest pressure during the infusion. These symptoms stopped as soon as the drip was turned off, but they were intense enough to require slowing the infusion rate, which is why sessions drag on for over an hour and a half on average.

A narrative review of the existing literature on IV NAD+ echoed these findings, listing nausea, cramping, flushing, and chest discomfort as commonly reported side effects.¹⁰ The review also flagged a significant gap: long-term safety data simply do not exist yet. Most studies and clinic protocols track patients over days or weeks, not months or years. If you are considering repeated infusions over a long period, you are stepping beyond what the current evidence can speak to.

The Conditions People Seek It For

NAD IV therapy is marketed for a broad list of conditions and goals. Some have more scientific grounding than others.

Addiction and Substance Use

This is one of the oldest clinical uses of IV NAD+, dating back decades. Research into NAD+ and addiction has been reinvigorated by the discovery that NAD-dependent enzymes influence signaling pathways connected to the neurobiology of addictive behavior, including cravings and withdrawal symptoms.¹¹ A study of 50 patients with substance use disorder found that NAD+ infusions produced significant reductions in craving scores, anxiety, and depression, with the improvements following a dose-dependent trend. In a urine analysis of a subset of 40 patients conducted during the study, none tested positive for illicit substances.¹²

These results are encouraging but have serious limitations. The study had no placebo control group, so there is no way to separate the pharmacological effects of NAD+ from the effects of being in a structured clinical setting with frequent monitoring and support. Addiction treatment involves so many confounding factors that uncontrolled studies can only suggest a direction, not prove a treatment works. Larger, placebo-controlled trials are needed before anyone can say with confidence that NAD+ infusions are effective for addiction.

Neurodegenerative Disease

NAD+ plays key roles in how neurons adapt to stress and maintain their function, which has made it a subject of interest in diseases like Alzheimer’s, Parkinson’s, and Huntington’s.¹³ Most of this research is preclinical, involving cell cultures and animal models. One randomized trial of nicotinamide riboside (an NAD+ precursor, not IV NAD+ itself) in Parkinson’s patients found that supplementation boosted the NAD metabolome and activated genes related to mitochondrial and cellular housekeeping functions.¹⁴ The researchers described it as “potential neuroprotective therapy” warranting further study, not a proven treatment. The gap between molecular changes in blood cells and actual slowing of neurodegeneration in the brain is vast.

Post-COVID Fatigue

One pilot study tested a combination of low-dose naltrexone and NAD+ supplementation (delivered via skin patches, not IV) in 36 patients with persistent fatigue after COVID-19. After 12 weeks, participants showed significant improvements in quality-of-life scores and reductions in fatigue, with about half of patients qualifying as responders.¹⁵ Separately, researchers have laid out a biological rationale for why COVID-19 might disrupt NAD+ metabolism, proposing IV NAD+ as a potential intervention for post-acute COVID syndrome.¹⁶ The combination design of the pilot study makes it impossible to determine whether NAD+ or naltrexone (or neither, given the lack of a control group) was responsible for the improvements.

What the Evidence Is Actually Strong Enough to Support

If you read the marketing materials for NAD IV clinics, you will encounter claims about anti-aging, cognitive enhancement, athletic performance, immune boosting, and metabolic optimization. The gap between these claims and the published evidence is substantial. Most of the foundational science on NAD+ comes from cell cultures and rodent models. The handful of human studies are almost all small pilot trials, uncontrolled case series, or retrospective analyses. No large, randomized, placebo-controlled trial has demonstrated that IV NAD+ produces a clear clinical benefit for any specific condition in humans.

That does not mean the treatment is worthless. It means the evidence is not mature enough to make definitive claims. The biological rationale is plausible: NAD+ genuinely is important for cellular function, its levels genuinely do decline with age, and restoring those levels in lab animals genuinely does improve certain health markers. Whether the same logic holds when you infuse NAD+ into a human vein, whether enough of it reaches the right cells in the right form, and whether the clinical effects exceed what a placebo would produce are questions that remain largely unanswered.

NAD+ IV Versus Oral Precursors

You do not have to get an IV to raise your NAD+ levels. Oral supplements of NAD+ precursors, particularly nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), have become popular consumer products. These smaller molecules survive digestion and get converted to NAD+ inside cells. The NADPARK trial in Parkinson’s patients, for instance, used oral NR and still saw measurable changes in the NAD metabolome.¹⁴

The pilot trial comparing IV NR directly to IV NAD+ found that NR produced a faster initial spike in whole-blood NAD+ (about a 21% increase at 3 hours versus no detectable change for NAD+ IV at that time point), while NAD+ IV showed a more gradual, delayed rise.⁹ NR IV was also far better tolerated, with only mild tingling and cramping compared to the moderate-to-severe gastrointestinal distress caused by NAD+ IV.⁶

This raises an uncomfortable question for NAD+ IV advocates: if a precursor molecule can raise NAD+ levels more quickly, with fewer side effects, and at a fraction of the cost, what is the specific advantage of infusing NAD+ itself? Proponents argue that the direct molecule might reach tissues in ways that precursors cannot, or that some of the clinical effects come from NAD+ acting on extracellular receptors before it gets broken down. These are hypotheses, not established facts. The comparative data available so far do not obviously favor IV NAD+ over precursor supplementation.

The Cancer Question

One concern that does not get enough attention in wellness-clinic marketing is the relationship between NAD+ and cancer. Cancer cells, like all rapidly dividing cells, have high energy demands. Research has shown that elevated NAD+ levels can enhance the metabolic pathways cancer cells rely on for growth, and that the rate-limiting enzyme for NAD+ synthesis is frequently amplified in several types of cancer.¹⁷ In fact, drugs that deplete NAD+ in tumors are being explored as potential cancer treatments.

This does not mean that getting NAD+ IV will give you cancer. The relationship between circulating NAD+ and tumor behavior in a living person is far more complicated than what happens in a petri dish. But it does mean there is a legitimate theoretical concern about pushing NAD+ levels artificially high, particularly in people who might have undetected cancers. This area is genuinely understudied in the context of IV therapy, and clinics that frame NAD+ as universally beneficial without mentioning this nuance are being incomplete.

Lifestyle Factors That Raise NAD+ Without a Needle

Before spending hundreds or thousands of dollars on IV infusions, it is worth knowing that several ordinary lifestyle habits have been shown to increase cellular NAD+ levels. Exercise, fasting, caloric restriction, and even exposure to heat (like sauna use) all appear to upregulate the body’s own NAD+ production.¹⁸ The proposed mechanism is that these mild stressors activate the same metabolic pathways that NAD+ supplementation targets, essentially encouraging cells to make more of the molecule on their own.

This research offers an interesting reframing: some of the health benefits long attributed to exercise and intermittent fasting may actually work, at least in part, through their effects on NAD+ metabolism. It also provides context for the IV therapy claims. If your NAD+ levels are low partly because of a sedentary lifestyle and poor diet, addressing those factors directly could accomplish some of what the infusion promises, while also improving dozens of other health markers that NAD+ alone does not touch.

The Role of Sirtuins and DNA Repair

Much of the excitement around NAD+ therapy traces back to sirtuins, a family of enzymes sometimes called “longevity genes” in popular media. Sirtuins use NAD+ as fuel to carry out chemical modifications on other proteins, influencing processes like inflammation, metabolism, and cellular stress responses. They also play direct roles in DNA repair by modifying repair factors and changing how accessible damaged DNA is to the repair machinery.¹⁹ When NAD+ levels are low, sirtuin activity drops, and some of these protective functions slow down.

The logic connecting sirtuins to IV therapy goes like this: if aging involves declining NAD+, and declining NAD+ means less sirtuin activity, and less sirtuin activity means worse DNA repair and more inflammation, then restoring NAD+ levels should reverse the chain. In animal models, this logic has held up reasonably well. In humans, we know that NAD+ precursors can increase measurable NAD+ levels and activate some sirtuin-related gene expression. What remains unproven is whether these molecular changes translate into the kind of health improvements, slower aging, better cognition, more energy, that clinics promise.

What a Typical Session Costs and Involves

NAD+ IV sessions at wellness clinics typically range from a few hundred to over a thousand dollars per infusion, with many protocols calling for multiple sessions over consecutive days or weeks. The treatment is not covered by standard health insurance because it is not FDA-approved for any specific medical condition. You will generally sit in a clinic chair for one to three hours while the drip runs, potentially longer if side effects require the infusion rate to be slowed. Some clinics add other nutrients to the IV bag, such as B vitamins, amino acids, or glutathione, though the evidence for these additions is similarly thin.

The experience is not passive. Many people report feeling flushed, nauseated, or crampy during the infusion, and staff often adjust the drip rate in response. Aftereffects can include fatigue on the day of treatment, followed by a subjective sense of improved energy or mental clarity in subsequent days. Whether that subsequent boost reflects a genuine pharmacological effect, a placebo response from an expensive and dramatic-feeling medical procedure, or simple recovery from the acute discomfort of the infusion itself is currently impossible to disentangle without proper controlled trials.

Regulation and Quality Control

NAD+ IV therapy exists in a regulatory gray zone. The NAD+ molecule itself is not a drug, so clinics can offer infusions as part of “wellness” or “integrative medicine” services without needing to demonstrate efficacy through the kind of trials that pharmaceutical drugs require. The quality of the NAD+ being infused, the sterility of preparation, the training of the person inserting the IV, and the monitoring protocols during infusion all vary from clinic to clinic. Some operate under physician supervision; others are staffed primarily by nurses or naturopaths.

If you are considering the treatment, asking specific questions about the source and purity of the NAD+, the qualifications of the staff, and what monitoring occurs during infusion is reasonable. Requesting information about emergency protocols for adverse reactions is also worthwhile, given that chest pressure and cardiac symptoms have been reported. The absence of regulation does not mean every clinic is unsafe, but it does mean the burden of vetting falls on you rather than on a regulatory body.

1
PubMed Central. NAD+ metabolism and its roles in cellular processes during ageing
2
PubMed Central. NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
3
PubMed Central. Fueling genome maintenance: On the versatile roles of NAD+ in preserving DNA integrity
4
PubMed Central. Age-related NAD+ decline
5
PubMed Central. The Role of NAD+ in Regenerative Medicine
6
PubMed Central. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting
7
PubMed Central. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD
8
PubMed Central. Connexin-43 hemichannels mediate cyclic ADP-ribose generation and its Ca2+-mobilizing activity by NAD+/cyclic ADP-ribose transport
9
bioRxiv. Randomized, placebo-controlled, pilot clinical study evaluating acute Niagen®+ IV and NAD+ IV in healthy adults
10
Frontiers in Aging. Narrative review of intravenous NAD+ and NAD+ precursors in wellness and translational medicine
11
PubMed Central. Sobriety and Satiety: Is NAD+ the Answer?
12
PubMed Central. Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty Cases
13
PubMed Central. NAD+ in Brain Aging and Neurodegenerative Disorders
14
PubMed. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease
15
PubMed Central. Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19
16
PubMed Central. Rationale for Nicotinamide Adenine Dinucleotide (NAD+) Metabolome Disruption as a Pathogenic Mechanism of Post-Acute COVID-19 Syndrome
17
PubMed Central. NAD Metabolism in Cancer Therapeutics
18
PubMed Central. Healthy Lifestyle Recommendations: Do the Beneficial Effects Originate from NAD+ Amount at the Cellular Level?
19
PubMed. Current role of mammalian sirtuins in DNA repair